RE: Another good day26 Jul 2023 07:55
Lynn Rees the man who ran yourgene into the ground happily discussing extended contracts with Illumina .
Trust me if we buy YGEN we do not want him anywhere near our board or team .
He certainly seems confident the deal will go through .
Five-year contract extension with Illumina
Manchester, UK - 26 July 2023: Yourgene (AIM: YGEN), a leading international molecular diagnostic group, announces that it has signed a five-year contract extension with Illumina Inc. ("Illumina"). The contract is a restated licence and supply agreement for Yourgene's sequencing based NIPT IVD products, which will now run until September 2028.
The restated licence provides seamless continuity for existing customers and allows Yourgene to continue its product development roadmaps for NIPT and other future applications in the field of precision medicine, as the Company looks to further penetrate key international markets such as Americas, UK, Europe and Australia.
Lyn Rees, Chief Executive Officer of Yourgene, commented: "We are delighted to continue our partnership with Illumina following a successful five years of working together to date. This provides us with a good opportunity to further develop exciting market opportunities in NIPT across many key markets."